India readies five sites for final phase of human trials of Oxford’s COVID-19 vaccine

Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine

The post India readies five sites for final phase of human trials of Oxford’s COVID-19 vaccine appeared first on Firstpost.

from http://www.firstpost.com/tech/science/india-readies-five-sites-for-final-phase-of-human-trials-of-oxfords-covid-19-vaccine-8647881.html